Medicina
Departamento
Hospital Virgen de La Luz de Cuenca
Cuenca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen de La Luz de Cuenca (88)
2024
-
Correction: Update on the management of elderly patients with colorectal cancer (Clinical and Translational Oncology, (2023), 26, 1, (69-84), 10.1007/s12094-023-03243-0)
Clinical and Translational Oncology
-
Update on the management of elderly patients with colorectal cancer
Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 69-84
2023
-
A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism
Thrombosis Update, Vol. 13
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
2022
-
A bacteraemia risk prediction model: development and validation in an emergency medicine population
Infection, Vol. 50, Núm. 1, pp. 203-221
-
Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
Clinical and Applied Thrombosis/Hemostasis, Vol. 28
-
Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
-
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Infectious Diseases and Therapy, Vol. 11, Núm. 3, pp. 1177-1192
-
Usefulness of the 5MPB-Toledo model to predict bacteremia in the elderly patient
Infectio, Vol. 26, Núm. 2, pp. 128-136
-
β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain
Frontiers in Medicine, Vol. 9
2021
-
Author Correction: Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America (Scientific Reports, (2021), 11, 1, (11442), 10.1038/s41598-021-90023-x)
Scientific Reports
-
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study
Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346
-
Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2
International Journal of Cardiology, Vol. 330, pp. 268-272